Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management
about
Anaesthesia and airway management in mucopolysaccharidosis.The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart FailureAortic Root Dilatation in Mucopolysaccharidosis I-VIINeonatal gene therapy with a gamma retroviral vector in mucopolysaccharidosis VI cats.Similar therapeutic efficacy between a single administration of gene therapy and multiple administrations of recombinant enzyme in a mouse model of lysosomal storage diseaseThe factors affecting lipid profile in adult patients with MucopolysaccharidosisResidual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6 years of enzyme replacement therapy: Implications for early diagnosis and therapy.Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin America.Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experience.Laronidase replacement therapy and left ventricular function in mucopolysaccharidosis I.Long-term functional outcomes of children with hurler syndrome treated with unrelated umbilical cord blood transplantation.Heart and Cardiovascular Involvement in Patients with Mucopolysaccharidosis Type IVA (Morquio-A Syndrome)Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients.Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI.Mucopolysaccharidosis Type II and the G374sp Mutation.Endothelial function in children and adolescents with mucopolysaccharidosis.Fatal and unanticipated cardiorespiratory disease in a two-year-old child with hurler syndrome following successful stem cell transplant.Pregnancy in patients with mucopolysaccharidosis: a case seriesPathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.The effect of neonatal gene therapy with a gamma retroviral vector on cardiac valve disease in mucopolysaccharidosis VII dogs after a decadeLow-dose Gene Therapy Reduces the Frequency of Enzyme Replacement Therapy in a Mouse Model of Lysosomal Storage Disease.Cardiovascular Abnormalities in Egyptian Children with Mucopolysaccharidoses.Carotid intima-media thickness is increased in patients with mucopolysaccharidoses.Current and emerging management options for patients with Morquio A syndromeDiagnostic approach and differential diagnosis in patients with hypertrophied left ventricles.Lysosomal storage diseases--the horizon expands.Elosulfase Alfa: a review of its use in patients with mucopolysaccharidosis type IVA (Morquio A syndrome).Human-Induced Pluripotent Stem Cell-Based Modeling of Cardiac Storage Disorders.Hyaluronidase 2 Deficiency Causes Increased Mesenchymal Cells, Congenital Heart Defects, and Heart Failure.Mucopolysaccharidoses Causing Valvular Heart Disease: Report and Review of Surgical Management.Glycosaminoglycan metabolism defects and atherosclerosis: frequent association of endothelial dysfunction in patients with Mucopolysaccharidosis.Massive accumulation of glycosaminoglycans in the aortic valve of a patient with Hunter syndrome during enzyme replacement therapy.Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome.Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy.Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS)Murine hyaluronidase 2 deficiency results in extracellular hyaluronan accumulation and severe cardiopulmonary dysfunctionMortality in patients with Sanfilippo syndrome.Cardiac manifestations in mucopolysaccharoidosisManagement of difficult airway with laryngeal mask in a child with mucopolysaccharidosis and mitral regurgitation: a case report.Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome).
P2860
Q26996429-BDA9763D-FD4F-4C8B-8E8D-ED04BBA561FAQ28546251-066A7EB9-14CA-44B2-8755-E82ABBA80C4EQ30367116-77231A00-92DC-4D4C-AA79-E436C8F1C5F4Q30513972-EC344F32-1956-4F4E-A105-1DBEF584B848Q30583745-ADB4305D-D9D1-495F-AA0D-4A2550F2605BQ33716134-9D2A2CF2-B1D7-4DC5-86D3-80417F438B2EQ33800119-46D2954D-1D96-498B-990B-FF31E3836E72Q33890337-E46E8052-3B0B-43F0-92DF-0A09967FE9B4Q34311268-7968B109-F622-4DF8-9D72-D98344927E7EQ34457702-E8F3256C-BDE0-4F03-8D2B-1D54E509A48BQ35220724-3BAD8832-6F8E-4E7E-982E-21F486F6DC81Q36127763-E8162A95-A2B7-444F-86C0-75A599F031CAQ36571573-0D2C31A8-76AA-41AC-A349-5D37F8EBBE5EQ36662835-F6ECDAED-4BEE-4A10-A528-09719BD9EFCCQ36883369-79F58D06-6CD9-4D40-9D7B-D0C20961C5C5Q36934361-A17162B4-DFF4-4113-B28D-56C66893E12DQ37127672-9FCB2C75-79DB-48FC-BC5B-628299C2C0FAQ37224435-2CC3233D-7302-48B1-B3F0-BFBD8147AE4CQ37238697-B4620584-D9BC-4B3D-A7CA-AA0DC073D0CAQ37238895-BCDEB756-43CB-4937-B242-A2722037276FQ37507816-E9761E4D-88E4-4244-9A46-D66167AEC306Q37543239-62C64811-0128-4A5C-BCD8-864AEE9049B0Q37584874-B06477AE-04D9-4706-AF00-31843D39CBFCQ38081868-D7AD8C2B-AB4A-4799-9716-366DFAC21021Q38103225-95DAA1B8-E82C-4644-8598-C683D5A6F854Q38128478-366F53F1-1B99-40BF-BF31-EC2F6B33ED50Q38246994-69A9C5A2-7F3D-426D-82A6-824A4B4563ACQ38751652-24F0CEBC-964C-4723-9FC4-84D852229A85Q38961622-5BC00437-4EE1-4354-864C-D3414C9FC3DDQ39250206-AEE26F7B-8F40-410D-94B6-904978A00111Q40127329-7D0EE416-F427-4A9C-9D9C-B3F010322B5DQ41827061-5CD859EF-AEE1-47C4-88DE-AB2D721BFECEQ41980873-3F3242F6-2A06-4236-B48D-CEC434F9FCA8Q42176546-9261F99B-D74A-454B-9640-355B7E58ABAAQ42281140-C1A6E0C3-8DE8-4C34-9401-42E3961F774CQ42532970-20BC2488-9049-4038-B7B8-FAFCFE4CD1E3Q42644024-67EC6D6D-70B2-44B1-8596-FDA1861F7FC0Q42786507-F975260A-2E2B-4DD6-A1CB-2B1230990806Q43053241-D750B1EF-F4D0-4CFE-89F7-24A2EEF6D27FQ45874778-20A3919B-FB5C-4D2F-A992-8F4B3FF69710
P2860
Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cardiac disease in patients wi ...... tion, diagnosis and management
@ast
Cardiac disease in patients wi ...... tion, diagnosis and management
@en
type
label
Cardiac disease in patients wi ...... tion, diagnosis and management
@ast
Cardiac disease in patients wi ...... tion, diagnosis and management
@en
prefLabel
Cardiac disease in patients wi ...... tion, diagnosis and management
@ast
Cardiac disease in patients wi ...... tion, diagnosis and management
@en
P2093
P2860
P921
P1476
Cardiac disease in patients wi ...... tion, diagnosis and management
@en
P2093
Beatriz Furlanetto
Christoph Kampmann
Elizabeth A Braunlin
Howard M Rosenfeld
James P Loehr
Katherine P Ponder
Maurizio Scarpa
Paul R Harmatz
Roberto Giugliani
William C Roberts
P2860
P2888
P304
P356
10.1007/S10545-011-9359-8
P577
2011-07-09T00:00:00Z
2011-12-01T00:00:00Z